CGCF 10-K & 10-Q changes, risk factors and insider trading

Cartesian Growth Corp IV (also CGCFU, CGCFW) · Nasdaq · Blank Checks · CIK 2126043 · All filings on SEC.gov

Everything below is quoted or computed from Cartesian Growth Corp IV's public SEC filings. It is not a recommendation to buy or sell. Automated comparisons can contain errors; confirm with the original filing.

At a glance

0Form 4 filings reporting open-market purchases (last 180 days)

0Form 4 filings reporting open-market sales (last 180 days)

Jump to: Annual report (10-K) · Quarterly report (10-Q) · Insider transactions · 13F holders

What changed in the latest 10-K

Comparison not available: Not available: fewer than two 10-K filings on EDGAR to compare..

What changed in the latest 10-Q

Comparison not available: Not available: fewer than two 10-Q filings on EDGAR to compare (only one so far)..

CGCF insider buying and selling (Form 4)

Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.

No Form 4 stock transactions in this period.

Well-known investors holding CGCF (13F)

Investor	Quarter	Shares	Reported value	% of their 13F	Change vs prior quarter
Millennium Management (Israel Englander) UNIT 06/08/2031	2026-06-30	1,150,000	$11.5M	0.01%	New position
Two Sigma Investments UNIT 06/08/2031	2026-06-30	453,124	$4.5M	0.0%	New position

13F reports are filed up to 45 days after quarter end and show long U.S. equity positions only; options positions are omitted here.

Coming soon: email alerts when CGCF files, watchlists and downloadable comparisons.